//
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus
Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems